Only Lyme disease vaccine in development goes to Phase 3 trial

Vaccine maker Pfizer says it has begun Phase 3 clinical trial of its vaccine candidate against Lyme disease with French vaccine company Valneva SE. A black-legged tick, or otherwise known as deer tick, is pictured here.

Tags

As featured on